Ischaemic stroke demands immediate attention and a carefully planned approach to treatment. When blood flow to the brain becomes blocked, the race against time begins, but a range of established therapies and emerging research offer hope for preserving brain function, reducing disability, and supporting recovery after this life-changing event.

What medical teams aim to achieve when treating ischaemic stroke

When someone experiences an ischaemic stroke, treatment focuses on multiple goals that work together to give the person the best possible chance of recovery. The primary aim is to restore blood flow to the affected part of the brain as quickly as possible, because brain cells begin to die within minutes when deprived of oxygen^[1]. Every second truly counts in stroke care.

Treatment also aims to limit the damage that has already occurred and prevent further complications. This includes managing the immediate effects of the stroke, such as controlling blood pressure and preventing dangerous swelling in the brain. Healthcare teams work to address the underlying causes, like blood clots or narrowed arteries, to reduce the risk of another stroke happening in the future^[2].

The approach to treating ischaemic stroke varies considerably depending on several factors. The time elapsed since symptoms started plays a crucial role in determining which treatments are available. The severity of the stroke, which areas of the brain are affected, and the patient’s overall health condition all influence the treatment plan^[3]. For instance, someone who arrives at hospital within a few hours may be eligible for clot-busting medications, while someone who arrives later may need different interventions.

Importantly, treatment extends far beyond the initial emergency response. After the acute phase, care shifts toward rehabilitation and long-term management. This includes physical therapy to help regain movement, speech therapy for communication difficulties, and medications to manage risk factors like high blood pressure, high cholesterol, or irregular heart rhythms^[4]. The ultimate goal is not just survival, but helping each person regain as much independence and quality of life as possible.

There are well-established treatments that medical societies around the world have approved and recommend for ischaemic stroke. At the same time, researchers continue to explore new therapies through clinical trials, searching for ways to improve outcomes and expand treatment options for more patients^[5].

Established treatments used in everyday stroke care

The cornerstone of ischaemic stroke treatment involves breaking up or removing the blood clot that is blocking blood flow to the brain. There are two main ways doctors accomplish this, and both are time-sensitive^[3].

Clot-busting medication (thrombolysis)

The most widely used emergency treatment for ischaemic stroke is a medication called alteplase, also known as recombinant tissue plasminogen activator or r-tPA. This drug works by dissolving the blood clot, allowing blood to flow back to the starved brain tissue^[12]. Alteplase is given through a small tube inserted into a vein in the arm, and the medication then travels through the bloodstream to reach the clot in the brain.

The crucial limitation with thrombolysis is timing. For the treatment to be most effective and safe, it typically needs to be given within four and a half hours of when stroke symptoms first appeared^[14]. In some carefully selected cases, doctors may decide it could still help beyond this window, but generally, the earlier it is given, the better the outcome. This is why recognizing stroke symptoms immediately and calling emergency services without delay is so important.

Not everyone can receive thrombolysis. Medical teams must carefully check whether it is safe for each individual patient. For example, if brain imaging shows the stroke was caused by bleeding rather than a clot, thrombolysis would be dangerous. Other factors that may rule out this treatment include recent surgery, severe bleeding disorders, very mild or very severe stroke symptoms, or certain medications that don’t mix well with alteplase^[14].

During and after receiving alteplase, patients are closely monitored. Medical staff watch for signs of complications, particularly bleeding, which is the main risk associated with clot-busting medication. Blood pressure is carefully controlled, and patients typically need brain imaging again after treatment to ensure no bleeding has occurred^[14].

Mechanical clot removal (thrombectomy)

For strokes caused by blockages in larger blood vessels in the brain, doctors can sometimes physically remove the clot using a procedure called mechanical thrombectomy. A surgeon inserts a thin, flexible tube called a catheter through a small incision, usually in the groin, and carefully guides it through the blood vessels up to the brain^[11]. Special devices attached to the catheter can then grab and pull out the clot or break it up.

Thrombectomy has a longer time window than thrombolysis. It can be performed up to 24 hours after stroke symptoms begin in carefully selected patients^[4]. This extended window is particularly important for people who wake up with stroke symptoms and don’t know exactly when the stroke occurred.

Not all stroke patients need or are suitable for thrombectomy. It is most beneficial for strokes involving blockages in major arteries. Medical teams use brain imaging to identify which patients will benefit most from this procedure^[13].

Medications to prevent blood clots

After the immediate crisis is managed, patients receive medications to prevent new clots from forming or existing small clots from growing larger. Antiplatelet agents like aspirin or clopidogrel work by preventing blood cells called platelets from clumping together to form clots. These medications are usually started soon after stroke, unless the patient has received thrombolysis, in which case they are delayed for about 24 hours^[13].

For patients whose stroke was caused by certain heart conditions, particularly an irregular heartbeat called atrial fibrillation, doctors may prescribe stronger blood-thinning medications called anticoagulants. These work differently from antiplatelet drugs by affecting the blood’s clotting system itself^[6]. The choice of medication depends on what caused the stroke in the first place.

The main concern with all these medications is that by preventing clotting, they also increase the risk of bleeding. Doctors carefully weigh this risk against the benefit of preventing another stroke when choosing medications and doses for each patient^[13].

Managing blood pressure and other risk factors

Controlling blood pressure is a delicate balancing act in stroke treatment. In the first hours and days after a stroke, doctors generally allow blood pressure to remain somewhat elevated because this can help maintain blood flow to the damaged brain areas. However, if blood pressure becomes dangerously high, it must be lowered to prevent complications like bleeding in the brain^[13].

After the acute phase, long-term blood pressure management becomes crucial for preventing future strokes. Medications like ACE inhibitors, calcium channel blockers, or beta blockers may be prescribed. The specific choice depends on the individual patient’s blood pressure patterns and other health conditions^[13].

Patients also receive treatment for other conditions that increase stroke risk. This includes medications to lower cholesterol levels, drugs to control diabetes if present, and in some cases, procedures to open narrowed arteries in the neck that supply blood to the brain^[10].

Supportive care and monitoring

Beyond specific stroke treatments, patients receive comprehensive supportive care. This includes ensuring stable breathing and oxygen levels, controlling fever (which can worsen brain damage), managing blood sugar levels, and preventing complications like pneumonia or blood clots in the legs^[13].

For severe strokes that cause significant brain swelling, special treatments may be needed to control the pressure inside the skull. In rare cases, surgery to remove part of the skull temporarily may be necessary to relieve this dangerous pressure^[14].

Healthcare teams also watch for seizures, which can occur after stroke, and treat them with anti-seizure medications if they develop. Throughout the hospital stay, patients are regularly assessed to monitor their neurological status and detect any worsening or complications early^[13].

Duration of acute treatment

The intense emergency phase of stroke treatment typically lasts for the first few days in hospital. However, the total hospital stay varies widely depending on stroke severity. Some patients with minor strokes may be discharged within a few days, while those with severe strokes might remain hospitalized for weeks^[10]. After leaving the hospital, patients continue taking preventive medications indefinitely, often for the rest of their lives.

Innovative approaches being tested in clinical research

While current treatments have improved stroke outcomes significantly, researchers continue searching for new therapies that could help more patients or extend the time window for treatment. Clinical trials are investigating various innovative approaches, though these remain experimental and are not yet part of standard care^[13].

Neuroprotective strategies

One major area of research focuses on protecting brain cells from damage during and after a stroke. These neuroprotective approaches aim to keep brain tissue alive longer when blood flow is reduced, potentially extending the time window for treatments like thrombolysis or thrombectomy^[13].

Researchers are testing various molecules that might shield brain cells from the harmful effects of oxygen deprivation. Some experimental drugs work by blocking chemical reactions in brain cells that lead to cell death. Others try to reduce inflammation in the brain or protect the connections between brain cells. Despite decades of research and many promising results in laboratory studies, no neuroprotective drug has yet proven effective enough in large clinical trials to become an approved treatment^[13].

Part of the challenge is that stroke affects the brain in complex, interconnected ways, involving multiple damaging processes happening simultaneously. A drug that blocks one harmful pathway may not be enough if other destructive processes continue unchecked.

Advanced imaging to guide treatment

Clinical trials are exploring how newer imaging technologies can help identify which patients might benefit from treatment even outside the traditional time windows. Advanced brain scans can show which areas are already permanently damaged and which areas are still salvageable but at risk^[10].

This imaging-based approach, rather than relying solely on time since symptom onset, may allow more patients to receive treatments like thrombectomy. Some trials have shown positive results using these selection methods, and this approach is gradually being adopted in specialized stroke centers^[10].

Improvements to existing treatments

Research continues on refining current therapies. Scientists are testing whether combining different clot-busting drugs, or using them in different ways, might improve outcomes. Other studies examine optimal blood pressure targets during different phases of stroke recovery, or the best combinations of antiplatelet medications for preventing recurrent stroke^[13].

For mechanical thrombectomy, engineers and doctors work together to develop better devices that can remove clots more effectively and safely. Clinical trials test these new devices to ensure they improve outcomes before they are approved for widespread use^[11].

Understanding how trials work

Clinical trials for stroke treatments typically progress through phases. Phase I trials involve small numbers of participants and focus primarily on safety, determining if a new treatment causes unacceptable side effects. Phase II trials include more people and begin examining whether the treatment shows signs of effectiveness. Phase III trials are large studies comparing the new treatment against current standard care to determine if it truly improves outcomes^[13].

Most experimental treatments tested in trials do not ultimately prove effective enough to become approved therapies. This reality reflects the complexity of stroke and the high standards required to demonstrate that a new treatment truly helps patients. Even when a treatment shows promise in early studies, it may not hold up in larger, more rigorous trials.

Trial locations and patient eligibility

Clinical trials for ischaemic stroke treatments are conducted at medical centers around the world, including in the United States, Europe, and many other regions. However, not all trials are available at every location, and not every patient qualifies for every trial^[13].

Eligibility criteria for stroke trials typically consider factors like the time since symptom onset, stroke severity, the patient’s age and other health conditions, and what treatments have already been given. These criteria ensure participant safety and help researchers get clear answers about whether a treatment works for specific types of patients.

Most common treatment methods

• Thrombolysis (clot-busting medication)
  • Uses alteplase (tissue plasminogen activator or r-tPA) given through a vein to dissolve blood clots blocking brain arteries^[12]
  • Must typically be administered within 4.5 hours of symptom onset for safety and effectiveness^[14]
  • Main risk is bleeding in the brain or elsewhere in the body^[14]
  • Not suitable for all patients due to various medical contraindications^[14]
• Mechanical thrombectomy
  • Physical removal of blood clots using a catheter threaded from the groin to the brain^[11]
  • Can be performed up to 24 hours after symptom onset in selected patients^[4]
  • Most beneficial for blockages in large brain arteries^[13]
  • Requires specialized equipment and expertise available at comprehensive stroke centers^[11]
• Antiplatelet therapy
  • Medications like aspirin and clopidogrel that prevent blood clots from forming^[13]
  • Usually started soon after stroke and continued long-term to prevent recurrence^[6]
  • Work by preventing platelets in blood from clumping together^[13]
  • Main side effect is increased bleeding risk^[13]
• Anticoagulation therapy
  • Stronger blood-thinning medications for patients with specific causes like atrial fibrillation^[6]
  • Work by affecting the blood clotting system itself rather than just platelets^[6]
  • Require careful monitoring and dose adjustment^[13]
  • Carry higher bleeding risk than antiplatelet drugs but necessary for certain patients^[13]
• Blood pressure management
  • Careful control in acute phase, allowing some elevation to maintain brain blood flow^[13]
  • Long-term treatment with various medications like ACE inhibitors or beta blockers to prevent future strokes^[13]
  • Specific medications chosen based on individual patient characteristics^[13]
  • Critical for reducing risk of recurrent stroke^[10]
• Rehabilitation therapy
  • Physical therapy to help regain movement and strength after stroke^[17]
  • Occupational therapy to relearn daily activities like dressing and eating^[16]
  • Speech and language therapy for communication and swallowing problems^[17]
  • Should begin as soon as medically stable, sometimes even in the hospital^[17]